Influenza vaccination and myocarditis among patients receiving immune checkpoint inhibitors

Influenza vaccination and myocarditis among patients receiving immune checkpoint inhibitors

Background Influenza vaccination (FV) is recommended for patients with cancer. Recent data suggested that the administration of the FV was associated with an increase in immune-related adverse events (irAEs) among patients on immune checkpoint inhibitors (ICIs). Myocarditis is an uncommon but seriou...

Full description

Saved in:
Bibliographic Details
Main Authors: Anju Nohria, Stephane Ederhy, Franck Thuny, Michael Mahmoudi, Alexander R. Lyon, Ryan J. Sullivan, Javid J. Moslehi, Justine V. Cohen, Magid Awadalla, Doll Lauren Alexandra Golden, Syed S. Mahmood, Raza M. Alvi, Nathaniel D. Mercaldo, Malek Z. O. Hassan, Dahlia Banerji, Adam Rokicki, Connor Mulligan, Sean P. T. Murphy, Maeve Jones-O’Connor, Lucie M. Heinzerling, Merna Armanious, Rongras Damrongwatanasuk, Carol L. Chen, Dipti Gupta, Michael C. Kirchberger, Sachin P. Shah, Sarju Ganatra, Paaladinesh Thavendiranathan, Muhammad A. Rizvi, Gagan Sahni, Carlo G. Tocchetti, Valentina Mercurio, Donald P. Lawrence, John D. Groarke, Michael G. Fradley, Kerry L. Reynolds, Tomas G. Neilan
Format: Article
Language:English
Published: BMJ Publishing Group 2019-02-01
Series:Journal for ImmunoTherapy of Cancer
Online Access:https://jitc.bmj.com/content/7/1/53.full
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://jitc.bmj.com/content/7/1/53.full

Similar Items